Adenovirus Type 5 vector COVID-19 vaccine (inhaled)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adenovirus Type 5 vector COVID-19 vaccine (inhaled), covering 2023-02-08 to 2023-02-08. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation [Phase 1, Phase 2]